OBJECTIVE Analyze the nasal nitric oxide(NNO)of CRS children,and explore the clinical value of NNO in the diagnosis and treatment of CRS in children.METHODS CRS children diagnosed in the outpatient clinic were selected,and were divided into CRS with and without AR according to their allergen results.VAS score and NNO test were performed for them.Healthy children during the same period were selected as the control group.Finally their results were compared and analyzed.RESULTS The NNO of CRS children with and without AR were(193±62)ppb and(138±49)ppb,both lower than the control group's[(243±51)ppb];There were negative correlations between NNO and VAS scores in CRS children without AR before and after treatment;The NNO of CRS children with and without AR were significantly increased after treatment(P<0.05);NNO has high predictive value for diagnosing CRS children without AR(P<0.01).CONCLUSION The levels of NNO in different types of CRS were lower than normal,and CRS children without AR was lower than those with AR.NNO could assist in the diagnosis of CRS,dynamically reflect the severity of nasal inflammation,and help to distinguish the allergic status of CRS.

Objective: To design and establish a new method for flow cytometry-based detection of commonly observed highly expressed antigens on red blood cells, and to further evaluate the differences and distribution characteristics of antigen expression levels between ABO blood type homozygotes and heterozygotes in healthy individuals. Methods: Residual blood samples after donor blood type identification by Shanghai Blood Center in April 2024 were collected. Among them, samples of 19 homozygous and 19 heterozygous individuals of type A and type B were selected. Then the expression level of ABO antigen on red blood cells were detected using the new method established in this study and the traditional aldehyde fixed red blood cell method. Both methods were tested independently three times and the results were compared. Results: The mean values of the three detection results of the new method was (×10 /RBC): AA homozygous 3.3±0.5, AO heterozygous 2.8±0.3, BB homozygous 3.6±0.3, BO heterozygous 3.1±2.8. The mean values of the three detection results of the aldehyde fixation method were AA homozygous 5.9±0.9, AO heterozygous 5.0±1.4, BB homozygous 3.8±0.6, and BO heterozygous 3.3±0.4. The average antigen distribution of each genotype followed a normal distribution. Comparing the average antigen expression levels of homozygotes and heterozygotes, both methods showed that A/B homozygotes had higher antigen levels than heterozygotes, with AA being 1.17 to 1.18 times that of AO and BB being 1.15 to 1.16 times that of BO. Comparing the inter batch differences in the three test results of two methods, the new method showed no significant difference in the three test results for four genotypes (P>0.05). The aldehyde fixation method showed significant differences in the test results for all three genotypes (P<0.01) except for BB homozygotes (P>0.05). The reliability and reproducibility of the new method were better than those of the traditional aldehyde fixation method. Conclusion: The antigen expression level of ABO homozygotes is higher than that of heterozygotes, and the difference in antigen level between type A homozygotes and heterozygotes is slightly higher than that of type B. The new method is superior to traditional aldolization fixation methods.

Objective To detect the expression of sphingosine kinase 1(Sphk1)in colon cancer patients and colon cancer cells so as to explore the relationship between Sphk1 and oxaliplatin resistance in colon cancer.Methods The colon cancer RNA high-throughput sequencing data were downloaded from The Cancer Genome Atlas(TCGA),and the differences in Sphk1 expression in colon cancer tissues and normal tissues were analyzed.Human colon cancer SW48,HCT116,HT29 and LoVo cells were cultured,and the cells were randomly divided into blank control group,oxaliplatin group,transfected negative control siRNA group,transfected Sphk1 siRNA group,Sphk1 inhibitor dimethylsphingosine(DMS)group,and oxaliplatin and DMS combination group.Western blotting was used to detect the protein expressions of Sphk1 and phosphorylated Sphk1(p-Sphk1)in colon cancer cells.ELISA kits were used to detect Sphk1 activity and sphingosine-1-phosphate(S1P)content.MTT was used to detect the effect of oxaliplatin on cell viability.The nude mice planted tumor model of colon cancer cells was prepared and relevant interventions were performed.The tumor growth curve was drawn,and the expression of p-Sphk1 in the tumor was detected by Western blotting.Results The bioinformatics analysis of the colon cancer sequencing data in the TCGA database showed that the expression of Sphk1 in colon cancer tissues was significantly higher than that in normal tissues.Western blotting revealed that the expressions of Sphk1 and p-Sphk1 in HT29 and LoVo cells were higher than those in SW48 and HCT116 cells.ELISA detection found that the activity of Sphk1 in HT29 and LoVo cells was significantly higher than that in SW48 and HCT116 cells.MTT assay indicated that HT29 and LoVo cells showed drug resistance to oxaliplatin,and blocking the expression of Sphk1 with Sphk1 siRNA could restore the sensitivity of cells to oxaliplatin.Compared with the single application,the combined application of DMS and oxaliplatin could synergistically inhibit the viability of tumor cells,the activity of Sphk1 and the expression of S1P.In the nude mouse xenograft tumor models of colon cancer cells,the inhibitory effect of the combined administration of oxaliplatin and DMS on the growth of xenograft tumors was significantly stronger than the inhibitory effect of the single administration group,and it could synergistically reduce the expression of p-Sphk1 in the xenograft tumors and the concentration of S1P in the animal serum.Conclusion The expression and activation of Sphk1 are related to the sensitivity of colon cancer to oxaliplatin.Blocking Sphk1 can reverse the resistance of colon cancer cells to oxaliplatin and enhance the effects of oxaliplatin in vitro and in vivo.

The aim of the experiment was to study the effects of Echinacea purpurea extract on the digestive ability,immune function and intestinal barrier of the Bamei ternary pigs.Forty-eight healthy pigs of 50 days old were randomly divided into four groups,each with three replicates and four pigs in each replicate.The control group(CON)was fed a basal diet,and the experimental group was divided into 5 g/kg(T1),10 g/kg(T2)and 15 g/kg(T3)of Echinacea extract in the basal diet.The pre-test period was 5 days and the main test period was 35 days with free feeding and drinking during the test period.The results showed that:There was no significant effect on the apparent digestibility of nutrients and jejunum morphology in the test group compared to the CON group(P＞0.05).Amylase and trypsin activities were significantly higher in the experimental group and lipase activities were significantly higher in T2 and T3 groups compared to CON group(P＜0.05).GSH,CAT and T-AOC activities were significantly higher in the experimental group compared to CON group(P＜0.05).In comparison with CON group,the levels of IL-1 and IL-6 were significantly lower in the experimental group(P＜0.05),and the levels of TNF-α were significantly lower in the T2 and T3 groups(P＜0.05);and the levels of IL-10 were signifi-cantly higher in the T3 group(P＜0.05).The mRNA and protein expression levels of TLR4,MyD88,TRAF6,and NF-κB were significantly lower in the experimental group(P＜0.05).The mRNA and protein expression levels of CLDN-1,OCLN and ZO-1 were significantly increased in the test group(P＜0.05).The results between the test groups showed that the protein expression levels of CLDN-1 and OCLN were significantly increased in the T3 group compared with the T1 group(P＜0.05).In conclusion,the addition of Echinacea extract to the ration can,to a certain ex-tent,improve the digestive ability,balance the immune ability,and improve the intestinal barrier function of the Bamei ternary pigs,thus promoting the intestinal health of pigs.

This article summarized the overview of voice training, common training forms, and the application effect of voice training in the treatment of speech disorders in Parkinson′s disease patients, analyzed the shortcomings of its application and put forward prospects for future research, aiming to provide valuable references for both patients and healthcare workers.

This article summarized the overview of voice training, common training forms, and the application effect of voice training in the treatment of speech disorders in Parkinson′s disease patients, analyzed the shortcomings of its application and put forward prospects for future research, aiming to provide valuable references for both patients and healthcare workers.

Objective:A novel grass-root community screening and management model of hepatitis B was developed in order to improve the diagnosis and treatment rate of hepatitis B in Guangzhou city.Methods:A three-tier collaborative framework［tertiary hospitals-center for disease control and prevention（CDC）-primary care clinics］implemented dual-track screening（fixed-site+mobile units）using rapid hepatitis B surface antigen（HBsAg）testing and structured surveys. Digital closed-loop management integrated screening，referral，and follow-up. Data were analyzed via SPSS 26.0.Results:Among 30 012 community-dwelling adults screened（Male∶Female=1∶1.68），overall HBsAg positive rate was 5.21%（1 565/30 012），peaking in the 50-59-year cohort（ χ2=271.80， P<0.001）. Hepatitis B knowledge awareness was critically low（39.24%）. Of 140 referred HBsAg-positive individuals，15 chronic carriers required no immediate antiviral therapy per guidelines. Treatment linkage surged from 32.8%（41/125）to 86.4%（108/125）post-intervention. aMAP hepatocellular carcinoma（HCC）risk stratification（n=82）revealed low（36.6%），intermediate（32.9%），and high-risk（30.5%）profiles. Conclusions:This coordinated，digitally-enhanced strategy significantly improved hepatitis B detection and treatment access. However，persistent knowledge gaps underscore the imperative for targeted community education and adherence support.

Objective To detect the expression of sphingosine kinase 1(Sphk1)in colon cancer patients and colon cancer cells so as to explore the relationship between Sphk1 and oxaliplatin resistance in colon cancer.Methods The colon cancer RNA high-throughput sequencing data were downloaded from The Cancer Genome Atlas(TCGA),and the differences in Sphk1 expression in colon cancer tissues and normal tissues were analyzed.Human colon cancer SW48,HCT116,HT29 and LoVo cells were cultured,and the cells were randomly divided into blank control group,oxaliplatin group,transfected negative control siRNA group,transfected Sphk1 siRNA group,Sphk1 inhibitor dimethylsphingosine(DMS)group,and oxaliplatin and DMS combination group.Western blotting was used to detect the protein expressions of Sphk1 and phosphorylated Sphk1(p-Sphk1)in colon cancer cells.ELISA kits were used to detect Sphk1 activity and sphingosine-1-phosphate(S1P)content.MTT was used to detect the effect of oxaliplatin on cell viability.The nude mice planted tumor model of colon cancer cells was prepared and relevant interventions were performed.The tumor growth curve was drawn,and the expression of p-Sphk1 in the tumor was detected by Western blotting.Results The bioinformatics analysis of the colon cancer sequencing data in the TCGA database showed that the expression of Sphk1 in colon cancer tissues was significantly higher than that in normal tissues.Western blotting revealed that the expressions of Sphk1 and p-Sphk1 in HT29 and LoVo cells were higher than those in SW48 and HCT116 cells.ELISA detection found that the activity of Sphk1 in HT29 and LoVo cells was significantly higher than that in SW48 and HCT116 cells.MTT assay indicated that HT29 and LoVo cells showed drug resistance to oxaliplatin,and blocking the expression of Sphk1 with Sphk1 siRNA could restore the sensitivity of cells to oxaliplatin.Compared with the single application,the combined application of DMS and oxaliplatin could synergistically inhibit the viability of tumor cells,the activity of Sphk1 and the expression of S1P.In the nude mouse xenograft tumor models of colon cancer cells,the inhibitory effect of the combined administration of oxaliplatin and DMS on the growth of xenograft tumors was significantly stronger than the inhibitory effect of the single administration group,and it could synergistically reduce the expression of p-Sphk1 in the xenograft tumors and the concentration of S1P in the animal serum.Conclusion The expression and activation of Sphk1 are related to the sensitivity of colon cancer to oxaliplatin.Blocking Sphk1 can reverse the resistance of colon cancer cells to oxaliplatin and enhance the effects of oxaliplatin in vitro and in vivo.

The aim of the experiment was to study the effects of Echinacea purpurea extract on the digestive ability,immune function and intestinal barrier of the Bamei ternary pigs.Forty-eight healthy pigs of 50 days old were randomly divided into four groups,each with three replicates and four pigs in each replicate.The control group(CON)was fed a basal diet,and the experimental group was divided into 5 g/kg(T1),10 g/kg(T2)and 15 g/kg(T3)of Echinacea extract in the basal diet.The pre-test period was 5 days and the main test period was 35 days with free feeding and drinking during the test period.The results showed that:There was no significant effect on the apparent digestibility of nutrients and jejunum morphology in the test group compared to the CON group(P＞0.05).Amylase and trypsin activities were significantly higher in the experimental group and lipase activities were significantly higher in T2 and T3 groups compared to CON group(P＜0.05).GSH,CAT and T-AOC activities were significantly higher in the experimental group compared to CON group(P＜0.05).In comparison with CON group,the levels of IL-1 and IL-6 were significantly lower in the experimental group(P＜0.05),and the levels of TNF-α were significantly lower in the T2 and T3 groups(P＜0.05);and the levels of IL-10 were signifi-cantly higher in the T3 group(P＜0.05).The mRNA and protein expression levels of TLR4,MyD88,TRAF6,and NF-κB were significantly lower in the experimental group(P＜0.05).The mRNA and protein expression levels of CLDN-1,OCLN and ZO-1 were significantly increased in the test group(P＜0.05).The results between the test groups showed that the protein expression levels of CLDN-1 and OCLN were significantly increased in the T3 group compared with the T1 group(P＜0.05).In conclusion,the addition of Echinacea extract to the ration can,to a certain ex-tent,improve the digestive ability,balance the immune ability,and improve the intestinal barrier function of the Bamei ternary pigs,thus promoting the intestinal health of pigs.

Objective:A novel grass-root community screening and management model of hepatitis B was developed in order to improve the diagnosis and treatment rate of hepatitis B in Guangzhou city.Methods:A three-tier collaborative framework［tertiary hospitals-center for disease control and prevention（CDC）-primary care clinics］implemented dual-track screening（fixed-site+mobile units）using rapid hepatitis B surface antigen（HBsAg）testing and structured surveys. Digital closed-loop management integrated screening，referral，and follow-up. Data were analyzed via SPSS 26.0.Results:Among 30 012 community-dwelling adults screened（Male∶Female=1∶1.68），overall HBsAg positive rate was 5.21%（1 565/30 012），peaking in the 50-59-year cohort（ χ2=271.80， P<0.001）. Hepatitis B knowledge awareness was critically low（39.24%）. Of 140 referred HBsAg-positive individuals，15 chronic carriers required no immediate antiviral therapy per guidelines. Treatment linkage surged from 32.8%（41/125）to 86.4%（108/125）post-intervention. aMAP hepatocellular carcinoma（HCC）risk stratification（n=82）revealed low（36.6%），intermediate（32.9%），and high-risk（30.5%）profiles. Conclusions:This coordinated，digitally-enhanced strategy significantly improved hepatitis B detection and treatment access. However，persistent knowledge gaps underscore the imperative for targeted community education and adherence support.